Edition:
India

Viking Therapeutics Inc (VKTX.OQ)

VKTX.OQ on NASDAQ Stock Exchange Capital Market

11.08USD
1:30am IST
Change (% chg)

$0.44 (+4.14%)
Prev Close
$10.64
Open
$10.73
Day's High
$11.22
Day's Low
$10.26
Volume
5,523,876
Avg. Vol
474,992
52-wk High
$13.40
52-wk Low
$0.88

Latest Key Developments (Source: Significant Developments)

Viking Therapeutics Announces Proposed Public Offering Of Common Stock
Thursday, 7 Jun 2018 

June 6 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.VIKING THERAPEUTICS INC - INTENDS TO USE NET PROCEEDS FROM OFFERING FOR CONTINUED DEVELOPMENT OF ITS VK5211, VK2809 AND VK0214 PROGRAMS.  Full Article

Viking Therapeutics says Resale By Selling Stockholders Of Up To 2.6 Mln Shares
Thursday, 21 Dec 2017 

Dec 20 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS - RESALE BY SELLING STOCKHOLDERS OF UP TO 2.6 MILLION SHARES OF CO'S COMMON STOCK - SEC FILING.  Full Article

Sphera Funds Management Ltd Reports 7.43 Pct Passive Stake In Viking Therapeutics
Monday, 18 Dec 2017 

Dec 18 (Reuters) - Viking Therapeutics Inc ::SPHERA FUNDS MANAGEMENT LTD REPORTS 7.43 PERCENT PASSIVE STAKE IN VIKING THERAPEUTICS INC AS OF DECEMBER 7 - SEC FILING.  Full Article

Viking Therapeutics Announces Closing Of Public Offering
Tuesday, 12 Dec 2017 

Dec 11 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS ANNOUNCES CLOSING OF PUBLIC OFFERING OF COMMON STOCK.  Full Article

Viking Therapeutics Announces Pricing Of $12.8 Million Public Offering Of Common Stock
Thursday, 7 Dec 2017 

Dec 6 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS ANNOUNCES PRICING OF $12.8 MILLION PUBLIC OFFERING OF COMMON STOCK.VIKING THERAPEUTICS INC- ‍ANNOUNCED PRICING OF ITS PUBLIC OFFERING OF 5,130,435 SHARES OF ITS COMMON STOCK AT A PRICE TO PUBLIC OF $2.50 PER SHARE​.  Full Article

Viking Therapeutics Announces Proposed Public Offering Of Common Stock
Wednesday, 6 Dec 2017 

Dec 5 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.VIKING THERAPEUTICS - INTENDS TO USE NET PROCEEDS FROM STOCK OFFERING FOR CONTINUED DEVELOPMENT OF ITS VK5211, VK2809 AND VK0214 PROGRAMS.  Full Article

Viking Therapeutics reports third quarter 2017 financial results
Thursday, 9 Nov 2017 

Nov 8 (Reuters) - Viking Therapeutics Inc :Viking Therapeutics reports third quarter 2017 financial results and provides corporate update.Q3 loss per share $0.22.Q3 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S.  Full Article

Viking Therapeutics files for sale of up to 6.9 mln shares by selling stockholder
Wednesday, 18 Oct 2017 

Oct 17 (Reuters) - Viking Therapeutics Inc :Viking Therapeutics Inc files for sale of up to 6.9 million shares of co's common stock by selling stockholder Lincoln Park Capital Fund Llc‍‍​ - SEC filing.  Full Article

Viking Therapeutics files for common stock offering of up to 7.5 mln shares
Saturday, 3 Sep 2016 

Viking Therapeutics Inc : Files for common stock offering of up to 7.5 million shares of common stock by the selling stockholder aspire capital - SEC filing Source: (http://bit.ly/2c1blgi) Further company coverage: [VKTX.O] ((bangalore.newsroom@thomsonreuters.com;)).  Full Article

Viking Therapeutics reported Q2 EPS ($0.22)
Wednesday, 10 Aug 2016 

Viking Therapeutics Inc : Q2 loss per share $0.22 . Viking Therapeutics reports second quarter 2016 financial results and provides corporate update .Q2 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Viking Therapeutics Q1 Loss Per Share $0.08

* VIKING THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE